In the BioHarmony Drug Report Database

"Preview" Icon

Crofelemer

Mytesi (crofelemer) is a small molecule pharmaceutical. Crofelemer was first approved as Mytesi on 2012-12-31. It is used to treat diarrhea in the USA. The pharmaceutical is active against anoctamin-1 and cystic fibrosis transmembrane conductance regulator. Mytesi’s patent is valid until 2031-10-31 (FDA).

 

Trade Name

 

Mytesi
 

Common Name

 

crofelemer
 

ChEMBL ID

 

CHEMBL2108184
 

Indication

 

diarrhea
 

Drug Class

 

Polymers

Image (chem structure or protein)

Crofelemer structure rendering